Rovida Advisors’s AdvisorShares Pure US Cannabis ETF MSOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,200,000
Closed -$5.8M 7
2025
Q3
$5.8M Buy
1,200,000
+200,000
+20% +$788K 5% 7
2025
Q2
$2.4M Hold
1,000,000
2.13% 11
2025
Q1
$2.6M Hold
1,000,000
1.95% 11
2024
Q4
$3.79M Buy
1,000,000
+800,000
+400% +$4.32M 2.95% 11
2024
Q3
$1.43M Buy
+200,000
New +$1.42M 0.45% 22
2024
Q2
Sell
-316,147
Closed -$3.16M 32
2024
Q1
$3.16M Hold
316,147
1.1% 22
2023
Q4
$2.2M Hold
316,147
0.9% 16
2023
Q3
$2.51M Hold
316,147
0.95% 17
2023
Q2
$1.75M Hold
316,147
0.76% 16
2023
Q1
$1.81M Buy
+316,147
New +$2.09M 0.7% 19

Other funds holding MSOS

Rovida Advisors's MSOS Position: Q4 2025 in Review

Rovida Advisors sold out of AdvisorShares Pure US Cannabis ETF (MSOS) in Q4 2025, closing a stake of 1,200,000 shares — an estimated $5.8M sold.

Rovida Advisors first reported a position in MSOS in Q1 2023 and held it in 10 quarters. The position peaked at $5.8M in Q3 2025. 185 funds tracked by Wall St. Rank hold MSOS as of Q4 2025.

  • Rovida Advisors reported no remaining AdvisorShares Pure US Cannabis ETF position as of Q4 2025 after selling out during the quarter.
  • Rovida Advisors sold 1,200,000 AdvisorShares Pure US Cannabis ETF shares in Q4 2025, an estimated $5.8M.
  • Rovida Advisors first reported a position in AdvisorShares Pure US Cannabis ETF in Q1 2023 and held it in 10 quarters.
  • Rovida Advisors's AdvisorShares Pure US Cannabis ETF position peaked at $5.8M in Q3 2025.
  • 185 funds tracked by Wall St. Rank held AdvisorShares Pure US Cannabis ETF as of Q4 2025.

Based on Rovida Advisors's 13F filing for Q4 2025.